Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
Tacrolimus (Tac) intraindividual variability (TacIPV) in pediatric kidney transplant patients is only poorly understood. We investigated the impact of TacIPV on de novo donor-specific HLA antibodies (dnDSA) development and allograft rejection in Caucasian pediatric recipients of a living or deceased...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
15 February 2022
|
| In: |
Pediatric nephrology
Year: 2022, Volume: 37, Issue: 10, Pages: 2503-2514 |
| ISSN: | 1432-198X |
| DOI: | 10.1007/s00467-022-05426-3 |
| Online Access: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1007/s00467-022-05426-3 |
| Author Notes: | Maral Baghai Arassi, Laura Gauche, Jeremy Schmidt, Britta Höcker, Susanne Rieger, Caner Süsal, Burkhard Tönshoff, Alexander Fichtner |
| Summary: | Tacrolimus (Tac) intraindividual variability (TacIPV) in pediatric kidney transplant patients is only poorly understood. We investigated the impact of TacIPV on de novo donor-specific HLA antibodies (dnDSA) development and allograft rejection in Caucasian pediatric recipients of a living or deceased donor kidney with low immunological risk. |
|---|---|
| Item Description: | Gesehen am 07.03.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1432-198X |
| DOI: | 10.1007/s00467-022-05426-3 |